DCM
TMO icon

Decatur Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Decatur Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.24M Sell
4,564
-73
-2% -$39.6K 1.03% 28
2025
Q4 		$2.69M Sell
4,637
-237
-5% -$134K 1.09% 27
2025
Q3 		$2.36M Buy
4,874
+639
+15% +$297K 0.94% 29
2025
Q2 		$1.72M Hold
4,235
– – 0.75% 33
2025
Q1 		$2.11M Buy
4,235
+10
+0.2% +$5.42K 1.09% 27
2024
Q4 		$2.2M Sell
4,225
-62
-1% -$34.1K 1% 29
2024
Q3 		$2.65M Buy
4,287
+5
+0.1% +$2.96K 1.22% 24
2024
Q2 		$2.37M Buy
4,282
+114
+3% +$65.3K 1.15% 25
2024
Q1 		$2.42M Sell
4,168
-42
-1% -$23.6K 1.32% 22
2023
Q4 		$2.23M Buy
4,210
+307
+8% +$149K 1.34% 23
2023
Q3 		$1.98M Hold
3,903
– – 1.43% 20
2023
Q2 		$2.04M Sell
3,903
-55
-1% -$29.7K 1.39% 21
2023
Q1 		$2.28M Sell
3,958
-755
-16% -$426K 1.72% 13
2022
Q4 		$2.6M Hold
4,713
– – 1.87% 13
2022
Q3 		$2.39M Buy
4,713
+1
+0% +$560 1.81% 13
2022
Q2 		$2.56M Hold
4,712
– – 1.89% 12
2022
Q1 		$2.78M Buy
4,712
+459
+11% +$264K 1.62% 13
2021
Q4 		$2.84M Sell
4,253
-50
-1% -$31.2K 1.68% 14
2021
Q3 		$2.46M Sell
4,303
-5,128
-54% -$2.81M 1.62% 15
2021
Q2 		$4.76M Hold
9,431
– – 1.49% 16
2021
Q1 		$4.3M Sell
9,431
-8,524
-47% -$4.07M 1.48% 17
2020
Q4 		$8.36M Sell
17,955
-400
-2% -$188K 1.53% 15
2020
Q3 		$8.1M Buy
+18,355
New +$7.58M 1.6% 13

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Decatur Capital Management's TMO Position: Q1 2026 in Review

Decatur Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 1.6% in Q1 2026, selling an estimated $39.6K and leaving 4,564 shares worth $2.24M. The position accounts for 1.03% of the portfolio, ranked #28.

Decatur Capital Management first reported a position in TMO in Q3 2020 and has held it in 23 quarters since. The position peaked at $8.36M in Q4 2020. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Decatur Capital Management held 4,564 shares of Thermo Fisher Scientific worth $2.24M as of Q1 2026.
  • Decatur Capital Management sold 73 Thermo Fisher Scientific shares in Q1 2026, an estimated $39.6K.
  • Thermo Fisher Scientific made up 1.03% of Decatur Capital Management's portfolio in Q1 2026, its #28 holding.
  • Decatur Capital Management first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 23 quarters since.
  • Decatur Capital Management's Thermo Fisher Scientific position peaked at $8.36M in Q4 2020.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Decatur Capital Management's 13F filing for Q1 2026, filed 13 May 2026.